Jiangsu Lianhuan Pharmaceutical Co., Ltd.SSE: 600513

Announcement on Adding Extraordinary Proposal to the 4th Extraordinary General Meeting in 2025

· Issued by Jiangsu Lianhuan Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 4 pages · Chinese

Summary by 6ix AI

The proposal was submitted by a major shareholder and aims to enhance decision-making efficiency. The announcement confirms that the original meeting agenda remains unchanged despite the addition of this proposal.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Adding Extraordinary Proposal to the 4th Extraordinary General Meeting in 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Jiangsu Lianhuan Pharmaceutical Co., Ltd. on 6ix

Earlier from Jiangsu Lianhuan Pharmaceutical

Later from Jiangsu Lianhuan Pharmaceutical

All Jiangsu Lianhuan Pharmaceutical news releases